Title: An S, et al. Small-molecule PROTACs: An emerging and promising approach for the development of targeted therapy drugs. EBioMedicine. 2018 Oct;36:553-562
756525-98-1
1858264-36-4
2055040-99-6
2100306-52-1
2110449-02-8
2100306-51-0
100957-76-4 | 1-((1H-Indol-3-yl)methyl)piperidine-4-carboxylic acid | AA000380 | MFCD06739714
1010120-55-4 | 5-Bromo-[1,2,4]triazolo[1,5-a]pyridin-2-ylamine | AA0003G9 | MFCD11655928
1011722-07-8 | 2-Cyanopyridine-5-boronic acid | AA0003TB | MFCD10696633
1013405-79-2 | 3-[3-(Benzyloxy)phenyl]phenylacetic acid | AA00046X | MFCD20231507
101490-85-1 | Resorufin beta-d-glucopyranoside | AA0004IP | MFCD00037662
1015845-98-3 | 1-(4-Butylphenyl)-1H-pyrazole-4-carbaldehyde | AA0004TH | MFCD08691650
1016843-83-6 | Benzenepropanenitrile, 4-methyl-3-nitro-β-oxo- | AA00054R | MFCD09941734
1017793-59-7 | 1,6-Naphthyridine-3-carboxylic acid | AA0005HP | MFCD07366468
101909-42-6 | Methyl 4-chloro-1H-indole-3-carboxylate | AA0005UB | MFCD09841616
102-49-8 | (3,4-Dichlorophenyl)methanamine | AA00065U | MFCD00008114